Jun Sawa

Efficacy and safety of insulin glargine 300 U/<scp>mL</scp> vs insulin degludec in patients with type 2 diabetes: A randomized, open‐label, cross‐over study using continuous glucose monitoring profiles

Yuji Kawaguchi, Jun Sawa, Noriko Sakuma et al. · Journal of Diabetes Investigation · 2018 · 40 citations · Full text

Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring

Noritsugu Wada, Katsuhito Mori, Chie Nakagawa et al. · Journal of Diabetes and its Complications · 2015 · 27 citations

Metabolic Syndrome, Hemodialysis, Diabetes Management +9

Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec

Yuji Kawaguchi, Jun Sawa, Chie Hamai et al. · Diabetes Therapy · 2019 · 18 citations · Full text

Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika et al. · Advances in Therapy · 2022 · 15 citations · Full text

Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)

Yuji Kawaguchi, Jun Sawa, Chie Hamai et al. · Journal of Diabetes Investigation · 2019 · 10 citations · Full text